Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Database Update: Pharmaceutical Drug Export from Russia (September 2018) January 16, 2019

Wednesday, January 16, 2019

Between January and September 2018, Russia exported 16.1 bln RUB worth of pharmaceutical drugs (EEU countries excluded, customs duties included), which is in monetary terms 9.3% higher than that of the same period of 2017. In physical terms, the export volume is 0.37 bln units and the dynamics are -6%. If calculated in minimum dosage units (MDU), the dynamics are also negative, -9.4%.

In September 2018, Russia exported 2.32 bln RUB worth of pharmaceuticals, which is 20.3% higher than that of September 2017. It is also record-worthy; we saw higher dynamics only in May 2018 (+32%.)

Between January and September 2018, Russian-made pharmaceuticals accounted for nearly 59% of the export (compared to nearly 64% in 2017.) The number of exporting companies in 2018 was 338, while in 2017 it was 343.

Among the top 20 Russian exporting companies with the biggest export volume in monetary terms, Avexima has the highest dynamics (a 26 times increase.) It is followed by Promomed, with an 11 times increase. Ozon has the lowest dynamics (-39%), followed by Institute of Poliomyelitis and Viral Encephalitis n.a. M. Chumakov (-37%.) The latter, despite the fall, remains one of the leading exporters.

Dynamics of pharmaceutical drug export from Russia (EEU countries excluded) (2016 – 2017, January – September 2018)

Share: